References
- References
- Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327–36.
- Stetler-Stevenson WG, Krutzsch H, Wachner MP, Marguiles IMK, Liotta LA. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 1989;264:1353–6.
- Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE. Transforming growth factor P enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 1993;90:4577–81.
- Matrisan LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 1990;6:121–5.
- Pyke C, Ralfkiær E, Tryggvason K, Dan K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359–65.
- Liabakk NB, Talbot L, Smith RA, Wilkinson K, Balwill F. Matrix metalloproteinase 2 (MMP-2) and matrixmetalloproteinase (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996;56: 190–6.
- Jeriorska M, Haboubi NY, Schifield PF, Ogata Y, Nagase H, Woolley DE. Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int J Colorectal Dis 1994;9:141–8.
- Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, et al. 92kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996;65:57–62.